The DOI matches its OpenAlex record; 51 of the 51 references it cites were found in a registry or an index.
Possible involvement of pregnane X receptor–enhanced CYP24 expression in drug-induced osteomalacia
Open accessAbstract
Vitamin D controls calcium homeostasis and the development and maintenance of bones through vitamin D receptor activation. Prolonged therapy with rifampicin or phenobarbital has been shown to cause vitamin D deficiency or osteomalacia, particularly in patients with marginal vitamin D stores. However, the molecular mechanism of this process is unknown. Here we show that these drugs lead to the upregulation of 25-hydroxyvitamin D(3)-24-hydroxylase (CYP24) gene expression through the activation of the nuclear receptor pregnane X receptor (PXR; NR1I2). CYP24 is a mitochondrial enzyme responsible for inactivating vitamin D metabolites. CYP24 mRNA is upregulated in vivo in mice by pregnenolone 16alpha-carbonitrile and dexamethasone, 2 murine PXR agonists, and in vitro in human hepatocytes by rifampicin and hyperforin, 2 human PXR agonists. Moreover, rifampicin increased 24-hydroxylase activity in these cells, while, in vivo in mice, pregnenolone 16alpha-carbonitrile increased the plasma concentration of 24,25-dihydroxyvitamin D(3). Transfection of PXR in human embryonic kidney cells resulted in rifampicin-mediated induction of CYP24 mRNA. Analysis of the human CYP24 promoter showed that PXR transactivates the sequence between -326 and -142. We demonstrated that PXR binds to and transactivates the 2 proximal vitamin D-responsive elements of the human CYP24 promoter. These data suggest that xenobiotics and drugs can modulate CYP24 gene expression and alter vitamin D(3) hormonal activity and calcium homeostasis through the activation of PXR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, A. W. (1979) · Cited by 3,769
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
The Repressed Nuclear Receptor CAR Responds to Phenobarbital in Activating the Human CYP2B6 Gene
Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P., & Negishi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6043 · Cited by 668
Localized scleroderma-response to 1,25-dihydroxyvitamin D3
HUMBERT, P. G., DUPOND, J. L., ROCHEFORT, A., VASSELET, R., LUCAS, A., LAURENT, R., & AGACHE, P. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02127.x · Cited by 612
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Tebas, P., Powderly, W. G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S. L., & Yarasheski, K. E. (2000) · AIDS · doi:10.1097/00002030-200003100-00005 · Cited by 532
Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.
Kolars, J. C., Schmiedlin-Ren, P., Schuetz, J. D., Fang, C., & Watkins, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116064 · Cited by 528
Luo, G., Cunningham, M., Kim, S., Burn, T., Lin, J., Sinz, M., Hamilton, G., Rizzo, C., Jolley, S., Gilbert, D., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.795 · Cited by 442
De-orphanization of Cytochrome P450 2R1
Cheng, J. B., Motola, D. L., Mangelsdorf, D. J., & Russell, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307028200 · Cited by 404
Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor
Goodwin, B., Moore, L. B., Stoltz, C. M., McKee, D. D., & Kliewer, S. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12603-x · Cited by 374
Drocourt, L., Ourlin, J.-C., Pascussi, J.-M., Maurel, P., & Vilarem, M.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201323200 · Cited by 356
Self-citationSt‐Arnaud, R., Arabian, A., Travers, R., Barletta, F., Raval-Pandya, M., Chapin, K., Depovere, J., Mathieu, C., Christakos, S., Demay, M. B., et al. (2000) · Endocrinology · doi:10.1210/en.141.7.2658 · Cited by 336
Pascussi, J. M., Gerbal-Chaloin, S., Drocourt, L., Maurel, P., & Vilarem, M. J. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00483-x · Cited by 330
Self-citationTranscriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3
Thummel, K. E., Brimer, C., Yasuda, K., Thottassery, J., Senn, T., Lin, Y., Ishizuka, H., Kharasch, E., Schuetz, J., & Schuetz, E. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1399 · Cited by 325
Preece, M. A., O'Riordan, J. L. H., Lawson, D. E. M., & Kodicek, E. (1974) · Clinica Chimica Acta · doi:10.1016/0009-8981(74)90241-1 · Cited by 298
Chen, K.-S., & DeLuca, H. F. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(95)00060-t · Cited by 284
Regulation of CYP3A4 Expression in Human Hepatocytes by Pharmaceuticals and Natural Products
Raucy, J. L. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.5.533 · Cited by 249
Ohyama, Y., Ozono, K., Uchida, M., Shinki, T., Kato, S., Suda, T., Yamamoto, O., Noshiro, M., & Kato, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34094-2 · Cited by 231
Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application
Norman, A. W., Bouillon, R., & THOMASSET, M. (1991) · Cited by 230
The Function of Vitamin D Receptor in Vitamin D Action
Kato, S. (2000) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022662 · Cited by 216
Antiepileptic Drug–Induced Bone Loss in Young Male Patients Who Have Seizures
Andress, D. L. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.781 · Cited by 205
Pichard, L., Fabre, I., Daujat, M., Domergue, J., Joyeux, H., & Maurel, P. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09239-9 · Cited by 196
Self-citationPeptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXR
Dussault, I., Lin, M., Hollister, K., Wang, E. H., Synold, T. W., & Forman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100375200 · Cited by 189
Use of the nuclear receptor PXR to predict drug interactions
Moore, J. T., & Kliewer, S. A. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00300-0 · Cited by 188
Carlberg, C., & Polly, P. (1998) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v8.i1.20 · Cited by 186
The Nuclear Pregnane X Receptor Regulates Xenobiotic Detoxification
Kliewer, S. A. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.7.2444s · Cited by 165
Pichard‐Garcia, L., Gillet, G., Fabre, I., Dalet-Beluche, I., Bonfils, C., Thénot, J., & Maurel, P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08637-4 · Cited by 164
Self-citationBrown, A. J., Dusso, A., & Slatopolsky, E. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.2.f157 · Cited by 137
Rifampicin and vitamin D metabolism
Brodie, M. J., Boobis, A. R., Dollery, C. T., Hillyard, C. J., Brown, D. J., Maclntyre, I., & Park, B. K. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.115 · Cited by 104
Schmiedlin‐Ren, P., Thummel, K. E., Fisher, J. M., Paine, M. F., & Watkins, P. B. (2001) · PubMed · Cited by 102
Mechanism of vitamin D action and its regulation
Dusso, A., & Brown, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9808140 · Cited by 101
Effect of rifampicin and isoniazid on vitamin D metabolism
Brodie, M. J., Boobis, A. R., Hillyard, C. J., Abeyasekera, G., Stevenson, J. C., MacIntyre, I., & Park, B. K. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.197 · Cited by 97
Akeno, N., Matsunuma, A., Maeda, T., Kawane, T., & Horiuchi, N. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1640339 · Cited by 97
Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children
Chung, S., & Ahn, C.-I. (1994) · Brain and Development · doi:10.1016/0387-7604(94)90125-2 · Cited by 94
Zou, A., Elgort, M., & Allegretto, E. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.19027 · Cited by 87
Emerging Bone Problems in Patients Infected with Human Immunodeficiency Virus
Mondy, K. E., & Tebas, P. (2003) · Clinical Infectious Diseases · doi:10.1086/367566 · Cited by 86
Fernández-Rivera, J., García, R., Lozano, F., Macías, J., García-García, J. Á., Mira, J. A., Corzo, J. E., Gómez-Mateos, J. M., Rueda, A., Sánchez‐Bursón, J., et al. (2003) · HIV Clinical Trials · doi:10.1310/4x0h-uvmj-bhyw-cpfb · Cited by 81
Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (Review)
Wikvall, K. (2001) · International Journal of Molecular Medicine · doi:10.3892/ijmm.7.2.201 · Cited by 72
Theodoropoulos, C., Demers, C., DELVIN, E. E., Ménard, D., & Gascon‐Barré, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01743.x · Cited by 65
Bertilsson, L., Tybring, G., Widén, J., et al. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00630.x · Cited by 63
Toell, A., Kröncke, K., Kleinert, H., & Carlberg, C. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10104 · Cited by 60
Bone Disorders in Human Immunodeficiency Virus Infection
Glesby, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375884 · Cited by 53
Pharmaceutical use of mouse models humanized for the xenobiotic receptor
Xie, W., & Evans, R. M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02251-1 · Cited by 53
The concept of multiple vitamin D signaling pathways.
Carlberg, C. (1996) · PubMed · Cited by 34
Tomita, S., Ohnishi, J.-I., Misao, N., & Ichikawa, Y. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90241-v · Cited by 32
Vitamin D receptor ontogenesis in rat liver
Segura, C., Alonso‐Sampedro, M., Fraga, C., et al. (1999) · Histochemistry and Cell Biology · doi:10.1007/s004180050403 · Cited by 31
Nuclear Receptors Orchestrate Detoxification Pathways
Roy‐Chowdhury, J., Locker, J. D., & Roy‐Chowdhury, N. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00131-x · Cited by 30
D'Erasmo, E., Ragno, A., Raejntroph, N., & Pisani, D. (1998) · PubMed · Cited by 24
The Influence of Phenobarbital on Biotransformation of 25‐Hydroxycholecalciferol
Burt, R. W., Freston, J. W., & Tolman, K. G. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02413.x · Cited by 13
Cited by
High Prevalence of Vitamin D Inadequacy and Implications for Health
Holick, M. F. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.353 · Cited by 2,005
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment
Tebben, P. J., Singh, R. J., & Kumar, R. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1070 · Cited by 442
Enzyme induction with antiepileptic drugs: Cause for concern?
Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03671.x · Cited by 383
Urquhart, B. L., Tirona, R. G., & Kim, R. B. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299930 · Cited by 373
Organotypic liver culture models: meeting current challenges in toxicity testing
LeCluyse, E. L., Witek, R. P., Andersen, M. E., & Powers, M. J. (2012) · Critical Reviews in Toxicology · doi:10.3109/10408444.2012.682115 · Cited by 363
Metadata
- Authors
- Pascussi, J., Robert, A., Nguyen, T. M., Walrant-Debray, O., Garabédian, M., Martin, P. G. P., Pineau, T., Saric, J., Navarro, F., Maurel, P., & Vilarem, M.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2005-01-03
- Volume
- 115
- Issue
- 1
- Pages
- 177-186
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2160202028
- Cited by
- 317
- References
- 51
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.